The authors, representatives of the "BEAT-ROP Cooperative Group," showed that intravitreal bevacizumab monoclonal antibody therapy in infants with stage 3+ retinopathy of prematurity showed a significant benefit for z…
The authors, representatives of the "BEAT-ROP Cooperative Group," showed that intravitreal bevacizumab monoclonal antibody therapy in infants with stage 3+ retinopathy of prematurity showed a significant benefit for z…